CD3G and inflammatory bowel disease: The symptoms are less severe in patients with CD3G mutations, and only two (20%) of all 10 published cases received HSCT due to refractory IBD, AIHA, and granulomatous lymphocytic interstitial lung disease or severe life-threatening infections.